谷氨酰胺
化学
营养感应
生物发生
肿瘤微环境
代谢途径
细胞生物学
串扰
mTORC1型
癌细胞
肿瘤细胞
功能(生物学)
新陈代谢
营养物
自噬
生物化学
癌症研究
脂锚定蛋白
细胞代谢
代谢调节
代谢活性
癌症治疗
运输机
TFEB
糖酵解
癌症
细胞
代谢网络
线粒体
线粒体生物发生
程序性细胞死亡
失巢
肿瘤进展
作者
Junrong Wang,Mengqian Xu,Guoqing Zhu,Shanshan Zhang,Yunlong Li,Ping'an Ma,Jun Lin,Chunxia Li
摘要
Tumor cells display a strong dependency on nutrients, yet nutrient-deprivation strategies often fail due to their metabolic plasticity and compensatory mechanisms, and can even promote invasion and metastasis. Here, we propose a metabolic therapeutic strategy that leverages rather than suppresses tumor nutrient addiction, termed "pseudo-overnutrition". This approach induces tumor cells to continuously uptake nutrient analogs that cannot be effectively utilized, thereby decoupling nutrient input from nutrient utilization and triggering metabolic collapse. To validate this concept, we designed and assembled rare-earth-coordinated glutamine nanoparticles (RE-Gln). RE-Gln preferentially interacts with glutamine transporters on tumor-cell membranes, is subsequently internalized predominantly through macropinocytosis, and accumulates within lysosomes. The progressive accumulation of RE-Gln disrupts V-ATPase-dependent lysosomal nutrient sensing and blocks mTORC1 activation, rendering cells unable to effectively utilize nutrients despite continuous uptake. Importantly, the resulting dysfunction is confined primarily to lysosomes, while mitochondrial integrity remains preserved. This lysosome-centered impairment ultimately causes widespread disruption of glutamine and glucose metabolism. Moreover, the high-glutamine microenvironment induced by RE-Gln impairs lysosomal biogenesis and function in dendritic cells, enhancing antigen presentation and activating antitumor immunity. These findings establish "pseudo-overnutrition" as a previously unrecognized concept for metabolic intervention in cancer and provide a mechanistic framework for converting tumor nutrient dependency into a therapeutic vulnerability.
科研通智能强力驱动
Strongly Powered by AbleSci AI